Skip Navigation



International Immunology Advance Access published online on May 20, 2005

International Immunology, doi:10.1093/intimm/dxh263
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/6/815    most recent
dxh263v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jimi, E.
Right arrow Articles by Ghosh, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jimi, E.
Right arrow Articles by Ghosh, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org
Received August 20, 2004
Accepted March 24, 2005

Article

Activation of NF-{kappa}B promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells

Eijiro Jimi 1 *, Roderick J. Phillips 2 *, Mercedes Rincon 3, Reinhard Voll 4, Hajime Karasuyama 5, Richard Flavell 6, and Sankar Ghosh 1*

1 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA
2 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA; Present address: Department of Physiology, UCLA, Los Angeles, CA 90401, USA
3 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Present address: Department of Medicine, University of Vermont, Burlington, VT 05405, USA
4 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA; Present address: Institute for Clinical Immunology, Friedrich-Alexander University, Erlangen, Germany
5 Department of Immune Regulation, Tokyo Medical and Dental University, Graduate School of Medicine, Tokyo 113-8519, Japan
6 Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA

* To whom correspondence should be addressed.
Sankar Ghosh, E-mail: sankar.ghosh{at}yale.edu


   Abstract

The regulation of the transcription factor nuclear factor-{kappa}B (NF-{kappa}B) during B-cell development was examined using cells isolated from the bone marrow of transgenic mice expressing a {kappa}B luciferase reporter gene. The results indicate that the highest level of NF-{kappa}B activity is present in cells expressing the pre-B-cell receptor. Furthermore, cross-linking of Ig{beta} on CD43+ pre-B cells is able to activate NF-{kappa}B in recombination-activating gene 1-deficient mice, preceding their further differentiation into CD43- pre-B cells. Expression of a dominant negative form of I{kappa}B{alpha} using a transgenic approach or by retroviral infection leads to a reduction in the number of CD43+ pre-B cells. These data therefore indicate that activation of NF-{kappa}B in CD43+ pre-B cells, as a result of signaling by the pre-B-cell receptor, facilitates the continued development of large, CD43+ pre-B cells into small CD43- pre-B cells.

Keywords: NF-kappa B; B-cells; lymphocytes; development; apoptosis.

*These authors contributed equally to the study.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JEMHome page
E. J. Cadera, F. Wan, R. H. Amin, H. Nolla, M. J. Lenardo, and M. S. Schlissel
NF-{kappa}B activity marks cells engaged in receptor editing
J. Exp. Med., August 3, 2009; 206(8): 1803 - 1816.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Claudio, S. Saret, H. Wang, and U. Siebenlist
Cell-Autonomous Role for NF-{kappa}B in Immature Bone Marrow B Cells
J. Immunol., March 15, 2009; 182(6): 3406 - 3413.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Igarashi, Y. Baba, Y. Nagai, E. Jimi, S. Ghosh, and P. W Kincade
NF-{kappa}B is dispensable for normal lymphocyte development in bone marrow but required for protection of progenitors from TNF{alpha}
Int. Immunol., May 1, 2006; 18(5): 653 - 659.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.